Estébanez-Perpiñá, EvaBevan, Charlotte LMcEwan, Iain J2021-04-152021-04-152021-01-29Estébanez-Perpiñá, E, Bevan, C L & McEwan, I J 2021, 'Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer : The Fight Goes on', Cancers, vol. 13, no. 3, 509. https://doi.org/10.3390/cancers130305092072-6694PubMedCentral: PMC7865914ORCID: 0000-0003-2087-0663https://hdl.handle.net/2164/16251Funding Information: The authors gratefully acknowledge funding support from: Prostate Cancer UK, Cancer Research UK Imperial Centre and Prostate Cancer Foundation (Bevan Lab); grants BFU2017-86906-R and SAF2017-90604REDT-NuRCaMeIn from the Spanish Ministry of Economy and Competitivity (MINECO, Gobierno de Espa?a), Caixa Impulse CI2018-00018 from La Caixa and Llavor-Generalitat de Catalunya (Estebañez-Perpiña Lab); Friends of Anchor, Prostate Cancer Research and Medical Research Council, grant MR/T02559X/1 (McEwan Lab).191562747engSDG 3 - Good Health and Well-beingAndrogen ablation therapyAndrogen receptorAntiandrogensProstate cancerR MedicineOncologyCancer ResearchCancer Research UKOtherBFU2017-86906-RSAF2017-90604REDTMedical Research Council (MRC)MR/T02559X/1Prostate Cancer UKREighty Years of Targeting Androgen Receptor Activity in Prostate Cancer : The Fight Goes onJournal item10.3390/cancers13030509https://www.scopus.com/pages/publications/85099975540